Evidence map›Paper›PMID 35069445›Full record

ArticleFrontiers in endocrinology2021

Case Report: Prophylactic Plate Fixation for Incomplete Atypical Ulnar Fractures Resulting From the Use of Denosumab for Bone Metastases.

Atsuro Murai, Kaoru Tada, Tadahiro Nakajima, Mika Akahane, Masashi Matsuta, Yuta Nakamura, Hiroyuki Tsuchiya

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Atsuro MuraiDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Kaoru TadaDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Tadahiro NakajimaDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Mika AkahaneDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Masashi MatsutaDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Yuta NakamuraDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Hiroyuki TsuchiyaDepartment of Orthopaedic Surgery, Graduate School of Medical Science Kanazawa University, Kanazawa, Japan.
Kanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with bone metastases are treated with long-term bone resorption inhibitors such as bisphosphonates and denosumab. However, resorption inhibitors have been known to cause fractures, such as atypical femoral fractures (AFFs). In recent years, there have been an increasing number of reports of atypical ulna fractures (AUFs) caused by bone resorption inhibitor usage. Treatment of AUFs is complicated, especially when they occur in patients with bone metastases, because it is difficult to discontinue bone resorption inhibitor treatment without the risk of aggravating metastatic lesions. Prophylactic surgery is recommended in AFFs when fractures are predicted, but there are few reports of prophylactic surgery for AUFs. Here, we report a case of incomplete AUF in a 74-year-old woman which was surgically treated with prophylactic plate fixation. The patient had been using denosumab for 6 years to treat bone metastases due to thyroid cancer. After surgery, no fractures were observed for 2 years without discontinuing denosumab, and her forearm function was adequate. AUFs are rare and difficult to treat, so oncologists who treat bone metastases need to pay special attention to diagnose this incomplete AUF before the fracture worsens. We believe that detection of a possible fracture and prophylactic surgery can improve prognosis.

Indexed as

Bone PlatesAdenocarcinoma, FollicularAgedBone Density Conservation AgentsBone NeoplasmsDenosumabFemaleFracture FixationHumansProphylactic Surgical ProceduresThyroid NeoplasmsUlna FracturesBone Density Conservation AgentsDenosumabatypical fracturebone metastasesdenosumabprophylactic fixationseverely suppression of bone turnoverulna

Identifiers

PMID35069445
PMCPMC8782234
OpenAlexW4205317404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.